We recently compiled a list of the 10 Stocks Mirror Wall Street Downturn. In this article, we are going to take a look at ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) was down 4.4% during mid-day trading on Friday after an insider sold shares in the company. The stock traded as low as $71.50 and last traded at $73.34.

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to ...

Tempus AI (TEM) and Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, announced a new collaboration. The two companies ...

There's still plenty of time for growth investors to click the buy button on Tempus AI stock; however, it's critical to ...

Tempus announced its acquisition of Ambry Genetics at closing in November and the deal closed earlier this month.

TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...

Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Thursday after the company announced a collaboration with the ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...

Tempus AI shares soared to an all-time high Thursday as the tech firm announced a collaboration with the nonprofit Institute ...